The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Peer-to-Peer (P2P) applications share resources and communicate in a decentralized or distributed architecture. Often application nodes communicate directly with each other or cooperate to do work ...

Among histologic risk factors, stage 3 (adjusted Hazard ratio (aHR) 2.68, 95% confidence interval (CI) 1.18–6.11) and stage 4 (aHR 6.96, 95% CI 3.55–13.64) fibrosis were associated with ...

The Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center will collaborate with GSK to develop stem cell-based models to better understand pulmonary fibrosis and ...

1 State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis ... potentially influencing the progression of organ fibrosis. This review ...

IS CYSTIC FIBROSIS STILL AN INDICATION FOR LUNG TRANSPLANTATION ... a frequent deletion in patients with CF. The patients with a pulmonary function between 40–50% and aged ≥12 years old were selected.

Increasing studies have shown IL-17 family cytokines are strongly associated with the initiation and propagation of myocardial fibrosis. This review summarizes the expression ... the occurrence and ...

1 PhD candidate of nursing, Department of Pediatric Nursing, Tabriz University of Medical Sciences, Tabriz, Iran (the Islamic Republic of) Background Cystic fibrosis (CF ... Objective This review ...

with FDA Breakthrough Therapy designation and peer-reviewed validation, supporting a "Strong Buy" rating. Denifanstat's unique FASN inhibition mechanism effectively reduces liver fibrosis ...